Conclusion Of Non-Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8/130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Filgotinib (L04Af04) Within The Framework Of A So-Called Open-House Model.

AOK Rheinland-Pfalz Saarland - Die Gesundheitskasse Germany has Released a tender for Conclusion Of Non-Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8/130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Filgotinib (L04Af04) Within The Framework Of A So-Called Open-House Model. in . The tender was released on Sep 18, 2024.

Country - Germany

Summary - Conclusion Of Non-Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8/130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Filgotinib (L04Af04) Within The Framework Of A So-Called Open-House Model.

Deadline - Aug 31, 2026

MT reference number - 93445532

Product classification - Transport services (excl. Waste transport)

Organization Details:

  Address - Germany

  Contact details - 565656565

  Tender notice no. - 76454545

  MT Ref Id - 93445532

  Document Type - Tender Notices

Notice Details and Documents:

Description - Description: Conclusion Of Non-Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8/130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Filgotinib (L04Af04) Within The Framework Of A So-Called Open-House Model .notice_title: Conclusion Of Non-Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8/130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Filgotinib (L04Af04) Within The Framework Of A So-Called Open-House Model.local description: : Abschluss nicht exklusiver Rabattverträge gemäß §§ 130a Abs. 8/130c Abs. 1 SGB V zu Arzneimitteln mit dem Wirkstoff Filgotinib (L04AF04) im Rahmen eines sogenannten Open-H

Mt Ref Id - 93445532

Deadline - Aug 31, 2026

Share

Similar Tenders :